Utilidad de la capilaroscopia en esclerodermia

Génessis Maldonado Vélez; Carlos Ríos Acosta

doi:10.47196/rar.v27i4.577

Génessis Maldonado Vélez Universidad de Especialidades Espíritu Santo, Samborondón, Ecuador
Carlos Ríos Acosta Centro de Reumatología y Rehabilitación, Guayaquil, Ecuador

DOI: https://doi.org/10.47196/rar.v27i4.577

Palabras clave: capilaroscopia del lecho ungueal, esclerodermia, patrón esclerodérmico (SD)

Resumen

La esclerosis sistémica (SSc) es una enfermedad del tejido conec-tivo caracterizado por una reactividad autoinmune, disfunción vas-cular generalizada y ﬁbrosis progresiva de la piel y órganos internos asociado a la producción de anticuerpos especíﬁcos. Durante los últimos años, la capilaroscopia ha demostrado ser una herramienta útil, reproducible y conﬁable para la evaluación inicial del fenómeno de Raynaud y enfermedades del tejido conectivo, en especial de la esclerodermia, siendo esta técnica incluida en los criterios diag-nósticos de la esclerodermia, lo que deja en evidencia la utilidad de esta técnica. A su vez la capilaroscopia asume un rol importante en la evaluación del compromiso sistémico, transición de la en-fermedad, manejo y predictor de mortalidad de la esclerodermia, aspectos que serán discutidos en esta revisión.

Biografía del autor/a

Génessis Maldonado Vélez, Universidad de Especialidades Espíritu Santo, Samborondón, Ecuador

Médico General

Carlos Ríos Acosta, Centro de Reumatología y Rehabilitación, Guayaquil, Ecuador

Médico Reumatólogo

Citas

I. Cutolo M, Sulli A, Pizzorni C, Paolino S, Smith V. Systemic sclerosis: markers and targeted treatments. Acta Reum Port. 2016;41:18–25.

II. Gabrielli A, Avvedimento E, Krieg T. Scleroderma. N Eng J Med. 2009;360:1989–2003.

III. Gottschalk P, Vásquez R, López P, Then J, Tineo C, Loyo E. Esclerodermia en el Caribe: características en una serie de casos dominicana. Reum Clin. 2014;10(6):373–9.

IV. Rosa J, Soriano E, Narvaez-Ponce L, Del Cid C, Imamura P, Cataggio L. Incidence and prevalence of systemic sclerosis in a healthcare plan in Buenos Aires. J Clin Rheumatol. 2011;17:59–63.

V. Scolnik M, Lancioni E, Saucedo C, Marin J, Sabelli M, Bedran Z, et al. Systemic sclerosis in Argentina: evaluation of a large cohort from a single centre and comparison with other international series. Clin Exp Rheumatol. 2014; 32(6 Suppl 86):S-94-7.

VI. Raynaud M. Thése de Médicine: De l’asphyxie locale et de la gangrene des extremités. Paris: Leclere. 1862;

VII. Ríos C, Maldonado G. Manual de Capilaroscopia [Internet]. Primera Ed. Guayaquil: Centro de Reumatología y Rehabilitación; 2016. 103 p. Available from: http://panlar.org/es/recursos_post_type/ manual-de-capilaroscopia/

VIII. Maricq H, Leroy E, D’Angelo W. Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders. Arthritis Rheum. 1980;23:183–9.

IX. Maricq H. Widefield capillary microscopy technique and Rating Scale for abnormalities seen in Scleroderma and Related Disorders. Arthritis Rheum. 1981;9:1159–65.

X. Hou M, Huang S, Wang C, Tseng L Lo, Chen Y. A computerized system of nail-fold capillaroscopy for dry eye disease diagnosis. Multidimens Syst Signal Process. 2012;23(4):512–24.

XI. Lefford F, Edwards J. Nailfold capillary microscopy in connective tissue disease: quantitative morphological analysis. Ann Rheum Dis. 1986;45:741–9.

XII. Hofstee H, Serné E, Roberts C. A multicentre study on the reliability of qualitative and quantitative nail-fold videocapillaroscopy assessment. Rheumatology. 2012;51(4):749–55.

XIII. G rassi W, Del Medico P. Atlas of Capillaroscopy. Milan: Edra Medical Publishing & New Media; 2004.

XIV. Cutolo M, Sulli A, Pizzorni C, Accardo S. Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol. 2000;27(155):60.

XV. Cutolo M, Grassi W, Cerinic MM. Raynaud's Phenomenon and the Role of Capillaroscopy. 2003;48(11):3023–30.

XVI. Cutolo M, Pizzorni C, Sulli A. Capillaroscopy. Best Pr Res Clin Rheumatol. 2005;3(437–52).

XVII. G REC - Grupo de Trabajo para el Estudio de la Capilaroscopia. Capilaroscopia. España; 2015.

XVIII. S ulli A, Sechi M, Pizzorni C, Cutolo M. Scoring the nailfold microvascular changes during the capillaroscopic analysis in systemic sclerosis patients. Ann Rheum Dis. 2008;67:885–7.

XIX. Smith V, De Keyser F, Pizzorni C, Van Praet J, Decuman S, Sulli A, et al. Nailfold capillaroscopy for day-to-day clinical use: construction of a simple scoring modality as a clinical prognostic index for digital trophic lesions. Ann Rheum Dis. 2011;70:180–3.

XX. Masi A, Rodnan G, Medsger JT, Altman R, D’Angelo W, Fries J. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum. 1980;23:581–90.

XXI. L onzetti L, Joyal F, Raynauld J. Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities makedly increases the sensitivity for limited scleroderma. Arthritis Rheum. 2001;44(735):6.

XXII. Hudson M, Taillefer S, Steele R, Dunne J, Johnson S, Jones N. Improving the sensitivity of the American College of Rheumatology classification criteria for systemic sclerosis. Clin Exp Rheumatol. 2007;25:754–7.

XXIII. Ziswiler H, Urech R, Balmer J, Ostensen M, Mierau R, Villiger P. Clinical diagnosis compared to classification criteria in in a cohort of 54 patients with systemic sclerosis and associated disorders. Swiss Med Wkly. 2007;137:586–90.

XXIV. L eRoy E, Black C, Fleismajer R, Jabolonska S, Krieg T, Medsger T. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988;15:202–5.

XXV. LeRoy E, Medsger TJ. Criteria for the classification of early systemic sclerosis. J Rheumatol. 2001;28(1573):6.

XXVI. A vouac J, Fransen J, Walker U. Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group. Ann Rheum Dis. 2011;70:476–81.

XXVII. H oogen V den. Classification Criteria for Sistemic Sclerosis. Arthritis Rheum. 2013;65:2737–47.

XXVIII. K oenig M, Joyal F, Fritzler MJ, Abrahamowicz M, Grodzicky T, Raymond Y, et al. Autoantibodies and Microvascular Damage Are Independent Predictive Factors for the Progression of Raynaud’ s Phenomenon to Systemic Sclerosis A Twenty-Year Prospective Study of 586 Patients , With Validation of Proposed Criteria for Early Systemic Sclero. 2008;58(12):3902–12.

XXIX. S pencer-Green G. Outcomes in primary Raynaud phenomenon: a metanalysis of the frequency, rates, and predictors of transition to secondary diseases. Arch Intern Med. 1998;(595–600).

XXX. Sulli A, Pizzorni C, Smith V, Zampogna G, Ravera F, Cutolo M. Timing of Transition Between Capillaroscopic Patterns in Systemic Sclerosis. 2012;64(3):821–5.

XXXI. Caramaschi P, Canestrini S, Martinelli N, Volpe A, Pieropan S, Ferrari M, et al. Scleroderma patients nailfold videocapillaroscopic patterns are associated with disease subset and disease severity. Rheumatology. 2007;46:1566–9.

XXXII. Riccieri V, Vasile M, Iannace N, Stefanantoni K, Sciarra I, Vizza C, et al. Systemic sclerosis patients with and without pulmonary arterial hypertension: a nailfold capillaroscopy study. Rheumatology (Oxford). 2013;52 (8)(1525):8.

XXXIII. Matucci-Cerinic M, D’Angelo S, Denton C, Vlachoyannopoulos P, Silver R. Assessment of lung involvement. Clin Exp Rheumatol. 2003;21(29):19–23.

XXXIV. Medsger TJ, Bombardieri S, Czirjak L, Scorza R, Della Rossa A, Bencivelli W. Assessment of disease severity and prognosis. Clin Exp Rheumatol. 2013;21(29):42–6.

XXXV. Sambarato D, Sambarato G, Zaccara E, Maglione W, Polosa R, Afeltra A, et al. Nailfold videocapillaroscopy micro-haemorrhage and giant capillary counting as an accurate approach for a steady state definition of disease activity in systemic sclerosis. Arthritis Res Ther. 2014;16(5):462.

XXXVI. Khanna D, Gladue H, Channick R, Chung L, Distler O, Furst D. Recommendations for screening and detection of connective tissue disease-associated pulmonary arterial hypertension. Arthritis Rheum. 2013;65(3194):201.

XXXVII. Sebastiani M, Manfredi A, Colaci M, D’Amico D, Malagoli V, Giuggioli D, et al. Capillaroscopic Skin Ulcer Risk Index: A New Prognostic Tool for Digital Skin Ulcer Development in Systemic Sclerosis Patients. Arthritis Rheum. 2009;61(5):688–94.

XXXVIII. Cutolo M, Herrick AL, Distler O, Becker M, Beltran E, Carpentier P, et al. Nailfold Videocapillaroscopic Features and Other Clinical Risk Factors for Digital Ulcers in Systemic Sclerosis A Multicenter, Prospective Cohort Study. Arthritis Rheumatol. 2016;68(10):2527–39.

XXXIX. Cutolo M, Sulli A, Sechi M, Olivieri M, Pizzorni C. The contribution of capillaroscopy to the differential diagnosis of connective autoimmune diseases. Best Pr Res Clin Rheumatol. 2007;21:1093–108.

XL. K ayser C, Sekiyama J, Próspero L, Camargo C, Andrade L. Nailfold capillaroscopy abnormalities as predictors of mortality in patients with systemic sclerosis. Clin Exp Rheumatol. 2013;31(76):103–8.

XLI. Van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis. 2013 Nov 1;72(11):1747–55.